RandyScottLongmanMD
Gastroenterology • New York, NYAssistant Professor, Medicine, Weill Cornell Medical College
Overview of Dr. Longman
Dr. Randy Longman is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from Weill Cornell Medicine and has been in practice 10 years. He is one of 303 doctors at New York-Presbyterian Hospital and one of 303 doctors at New York-Presbyterian Hospital who specialize in Gastroenterology. He has more than 70 publications and over 500 citings.
Office
1315 York Ave
Mezzanine
New York, NY 10021Fax+1 212-746-8144
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2009 - 2013- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2007 - 2009
Weill Cornell MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2008 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis Start of enrollment: 2020 Jan 31
Publications & Presentations
PubMed
- IgG-seq identifies immune-reactive enteric bacteria in Crohn's disease with spondyloarthritis.Grace A Maldarelli, Maeva Metz, Seun Oguntunmibi, Nancy Tran, Grace Xiang
Gut Microbes. 2025-12-01 - Biologic therapy for ulcerative colitis associated with immune thrombocytopenia.Manabu Nagayama, Yohei Funayama, Osamu Taniguchi, Kaoru Hatano, Kunihiko Oguro
Clinical Journal of Gastroenterology. 2024-10-01 - Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy.Rochelle Wong, Paris Charilaou, Amy Hemperly, Lihui Qin, Yushan Pan
Crohn's & Colitis 360. 2024-10-01
Authored Content
- Esophagitis Dissecans SuperficialisAugust 2011
Press Mentions
Possible Biomarker Identified for Crohn’s Disease with Arthritis TypeMarch 5th, 2025- Crohn’s Disease with Joint Inflammation Biomarker ID’dMarch 5th, 2025
- Dr. Randy Longman Receives NIH Director’s Transformative Research AwardOctober 8th, 2024
- Join now to see all
Grant Support
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)WEILL MEDICAL COLL OF CORNELL UNIV2021–2025
- Multidisciplinary Research Training in Gastroenterology and HepatologyWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
- Multidisciplinary Research Training in Gastroenterology and HepatologyWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
